earnings

Will St. Jude Medical (STJ) Disappoint this Earnings Season?
Yahoo/Zacks.com
Mon, 10/13/14 - 09:13 am
St. Jude Medical
earnings
devices
What to expect from Johnson & Johnson’s earnings
Marketwatch
Mon, 10/13/14 - 08:33 am
JNJ
earnings
Biomet's Q1 profits plunge despite sales increases
Mass Device
Fri, 10/10/14 - 10:51 am
earnings
Biomet
devices
Mylan Surges on Improved Q3 and Full-Year Earnings Outlook
Yahoo/Zacks.com
Mon, 10/6/14 - 06:42 pm
earnings
Mylan Labs
Will Biotech Beat This Earnings Season?
Barron's
Mon, 10/6/14 - 06:05 pm
earnings
Gilead Sciences
Celgene
Biogen Idec
Peregrine Pharmaceuticals' Q1 Loss Wider than Expected
Yahoo/Zacks.com
Wed, 09/10/14 - 08:55 am
Peregrine Pharmaceuticals
earnings
Aspen Shares Climb After Drugmaker’s Earnings Growth Quickens
Bloomberg
Fri, 08/29/14 - 10:15 am
Aspen Pharmacare
earnings
Will Seattle Genetics (SGEN) Crush Estimates at Its Next Earnings Report?
Yahoo/Zacks.com
Fri, 08/29/14 - 07:58 am
Seattle Genetics
earnings
Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again
Yahoo/Zacks.com
Fri, 08/22/14 - 12:06 pm
Gilead Sciences
earnings
Nobel Biocare silent on sale talks, raises profitability forecast
Reuters
Thu, 08/21/14 - 09:53 am
dental health
Nobel Biocare
M&A
earnings
Demand for Pacemakers Helps Medtronic Beat Estimates
Bloomberg
Tue, 08/19/14 - 08:09 am
earnings
devices
pacemakers
Medtronic
Jazz, Celgene Lead Top 4 Drugmaker Profit Margins
Investors.com
Mon, 08/18/14 - 04:21 pm
earnings
Jazz Pharmaceuticals
Celgene
Alexion
Regeneron
Biogen Idec: Drug Approval Offers ‘Underappreciated Earnings Upside,” Morgan Stanley Says
Barron's
Mon, 08/18/14 - 11:52 am
earnings
Biogen Idec
MS
multiple sclerosis
Plegridy
Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed
Yahoo/Zacks.com
Fri, 08/15/14 - 11:34 am
Merck KGaA
earnings
Boston Scientific Poised on Core Market Stabilization
Yahoo/Zacks.com
Thu, 08/14/14 - 03:56 pm
earnings
devices
Boston Scientific
Insys' Q2 sales nearly triple
Yahoo/Investors Business Daily
Wed, 08/13/14 - 08:16 am
earnings
INSYS Therapeutics
Medivation Jumps on Q2 Earnings Beat, Outlook Encourages
Yahoo/Zacks.com
Mon, 08/11/14 - 11:53 am
earnings
Medivation
Alnylam's Q2 Loss Wider-than-Expected, Pipeline in Focus
Yahoo/Zacks.com
Mon, 08/11/14 - 11:53 am
earnings
Alnylam
Osiris Falls despite Narrower Q2 Loss and Higher Revenues
Yahoo/Zacks.com
Mon, 08/11/14 - 11:52 am
Osiris
earnings
Neurocrine To Move Tardive Dyskinesia Drug Into Phase 3
Yahoo/Zacks.com
Fri, 08/8/14 - 05:55 pm
tardive dyskinesia
Neurocrine Biosciences
NBI-98854
earnings

Pages